What does Health & Life Co., Ltd. do?

Health & Life Co., Ltd. (1781.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 1781.TWO's market cap?

Health & Life Co., Ltd. (1781.TWO) has a market capitalization of approximately $509.6 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 1781.TWO pay a dividend?

Yes — Health & Life Co., Ltd. (1781.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 1781.TWO profitable?

Health & Life Co., Ltd. (1781.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

1781.TWO

Health & Life Co., Ltd.

TWO·Medical, Devices · Healthcare

NT$10.75NT$0.00+0.00%

Market capNT$509.63M·Market closed·Aug 27 5:02 AM UTC

Price Chart

NT$10.75+NT$0.00 (+0.00%)today

−25.35%CAGR −5.68%

Select date range

FromTo

Dec 31, 2007Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

1781.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 13

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$400.09M

Net Income−NT$50.67M

Net Margin−12.7%

Operating Cash Flow−NT$16.54M

Capital ExpendituresNT$8.80M

Free Cash Flow−NT$25.33M

Return on Equity−16.7%

Return on Invested Capital−3.1%

Net CashNT$24.38M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 1781.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 1781.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 1781.TWO and 80,000+ other tickers.

About Health & Life Co., Ltd.

Health & Life Co., Ltd. is a global provider of medical devices. Established in 1996 and headquartered in New Taipei City, Taiwan, the company specializes in developing and distributing solutions for critical health sectors, including cardiovascular health, in-vitro diagnostics, and respiratory care. Its diverse product line encompasses advanced vibrating mesh nebulizers, blood pressure monitoring systems, infrared thermometers, and various hearing aid technologies.

CEO: Guo-He Yang
Sector: Healthcare
Industry: Medical - Devices
Exchange: TWO
Employees: 120
Website: www.healthandlife.com.tw

Peers

Peers Tab

6758.TWO

A-SPINE Asia Co., Ltd.

Cap

NT$392.0M

4170.TWO

Vectorite Biomedical Inc.

Cap

NT$555.9M

6549.TWO

TaiwanJ Pharmaceuticals Co., Ltd.

Cap

NT$555.2M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 1781.TWO

What does Health & Life Co., Ltd. do?: Health & Life Co., Ltd. (1781.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 1781.TWO's market cap?: Health & Life Co., Ltd. (1781.TWO) has a market capitalization of approximately $509.6 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 1781.TWO pay a dividend?: Yes — Health & Life Co., Ltd. (1781.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 1781.TWO profitable?: Health & Life Co., Ltd. (1781.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.